• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危型子宫癌组织学亚型的种族差异:美国癌症统计研究。

Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.

机构信息

University of California, San Francisco School of Medicine, San Francisco, CA, USA.

Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

出版信息

Gynecol Oncol. 2021 May;161(2):470-476. doi: 10.1016/j.ygyno.2021.02.037. Epub 2021 Mar 13.

DOI:10.1016/j.ygyno.2021.02.037
PMID:33722415
Abstract

OBJECTIVE

Black women with uterine cancer on average have worse survival outcomes compared to White women, in part due to higher rates of aggressive, non-endometrioid subtypes. However, analyses of incidence trends by specific high-risk subtypes are lacking, including those with hysterectomy and active pregnancy correction. The objective of our study was to evaluate racial disparities in age-adjusted incidence of non-endometrioid uterine cancer in 720,984 patients.

METHODS

Data were obtained from United States Cancer Statistics using SEER*Stat. We used the Behavioral Risk Factor Surveillance System to correct for hysterectomy and active pregnancy. Age-adjusted, corrected incidence of uterine cancer from 2001 to 2016 and annual percent change (APC) were calculated using Joinpoint regression.

RESULTS

Of 720,984 patients, 560,131 (77.7%) were White, 72,328 (10.0%) were Black, 56,239 (7.8%) were Hispanic, and 22,963 (3.2%) were Asian/Pacific Islander. Age-adjusted incidence of uterine cancer increased from 40.8 (per 100,000) in 2001 to 42.9 in 2016 (APC = 0.5, p < 0.001). Black women had the highest overall incidence at 49.5 (APC = 2.3, p < 0.001). The incidence of non-endometrioid subtypes was higher in Black compared to White women, with the most pronounced differences seen in serous carcinoma (9.1 vs. 3.0), carcinosarcoma (6.1 vs. 1.8), and leiomyosarcoma (1.3 vs. 0.6). In particular, Black women aged 70-74 with serous carcinoma had the highest incidence (61.3) and the highest APC (7.3, p < 0.001).

CONCLUSIONS

Black women have a two to four-fold higher incidence of high-risk uterine cancer subtypes, particularly serous carcinoma, carcinosarcoma, and leiomyosarcoma, compared to White women after correcting for hysterectomy and active pregnancy.

摘要

目的

与白人女性相比,患有子宫癌的黑人女性的平均生存结果较差,部分原因是侵袭性、非子宫内膜样亚型的比例较高。然而,缺乏对特定高危亚型发病率趋势的分析,包括那些接受过子宫切除术和活产矫正的患者。本研究的目的是评估 720984 名患者中非子宫内膜样子宫癌的年龄调整发病率的种族差异。

方法

数据来自美国癌症统计数据,使用 SEER*Stat 获得。我们使用行为风险因素监测系统来校正子宫切除术和活产。使用 Joinpoint 回归计算 2001 年至 2016 年的年龄调整、校正后的子宫癌发病率和年百分变化(APC)。

结果

在 720984 名患者中,560131 名(77.7%)为白人,72328 名(10.0%)为黑人,56239 名(7.8%)为西班牙裔,22963 名(3.2%)为亚裔/太平洋岛民。子宫癌的年龄调整发病率从 2001 年的 40.8(每 100000 人)增加到 2016 年的 42.9(APC=0.5,p<0.001)。黑人女性的总体发病率最高,为 49.5(APC=2.3,p<0.001)。与白人女性相比,黑人女性的非子宫内膜样亚型发病率更高,其中浆液性癌(9.1 比 3.0)、癌肉瘤(6.1 比 1.8)和平滑肌肉瘤(1.3 比 0.6)的差异最为明显。特别是,70-74 岁患有浆液性癌的黑人女性的发病率最高(61.3),APC 最高(7.3,p<0.001)。

结论

在校正子宫切除术和活产因素后,与白人女性相比,黑人女性具有高风险的子宫癌亚型(尤其是浆液性癌、癌肉瘤和平滑肌肉瘤)的发病率要高出两到四倍。

相似文献

1
Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.高危型子宫癌组织学亚型的种族差异:美国癌症统计研究。
Gynecol Oncol. 2021 May;161(2):470-476. doi: 10.1016/j.ygyno.2021.02.037. Epub 2021 Mar 13.
2
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.子宫内膜癌组织学亚型的种族、民族和原籍国差异。
Gynecol Oncol. 2024 May;184:31-42. doi: 10.1016/j.ygyno.2024.01.009. Epub 2024 Jan 25.
3
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.美国亚裔/太平洋岛民、西班牙裔和非裔美国女性近期的乳腺癌发病趋势:按肿瘤亚型划分的变化
Breast Cancer Res. 2007;9(6):R90. doi: 10.1186/bcr1839.
4
Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.子宫切除术校正的子宫体癌发病趋势和相对生存率差异揭示了种族差异和非子宫内膜样癌发病率的上升。
J Clin Oncol. 2019 Aug 1;37(22):1895-1908. doi: 10.1200/JCO.19.00151. Epub 2019 May 22.
5
Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001-2003.2001 - 2003年美国子宫体癌发病率的种族和民族差异
J Womens Health (Larchmt). 2009 Mar;18(3):285-94. doi: 10.1089/jwh.2008.1171.
6
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.子宫内膜癌负担日益加重:影响黑人女性的重大种族差异。
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1407-15. doi: 10.1158/1055-9965.EPI-15-0316. Epub 2015 Aug 19.
7
Postpartum hemorrhage outcomes and race.产后出血结局与种族。
Am J Obstet Gynecol. 2018 Aug;219(2):185.e1-185.e10. doi: 10.1016/j.ajog.2018.04.052. Epub 2018 May 9.
8
Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype.按阶段和组织学亚型校正的子宫体癌死亡率的种族和民族差异。
JAMA Oncol. 2022 Jun 1;8(6):895-903. doi: 10.1001/jamaoncol.2022.0009.
9
Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010.马萨诸塞州 1995 年至 2010 年子宫切除术校正的宫颈癌和子宫癌发病率。
Ann Epidemiol. 2014 Nov;24(11):849-54. doi: 10.1016/j.annepidem.2014.07.018. Epub 2014 Aug 23.
10
Disparities in mortality-to-incidence ratios by race/ethnicity for female breast cancer in New York City, 2002-2016.2002-2016 年纽约市女性乳腺癌死亡率与发病率种族/民族差异分析。
Cancer Med. 2020 Nov;9(21):8226-8234. doi: 10.1002/cam4.3309. Epub 2020 Oct 2.

引用本文的文献

1
Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma.Wee1抑制剂adavosertib用于复发性子宫癌肉瘤的2期研究。
Gynecol Oncol Rep. 2025 Jun 24;60:101796. doi: 10.1016/j.gore.2025.101796. eCollection 2025 Aug.
2
Drug discovery in advanced and recurrent endometrial cancer: Recent advances.晚期和复发性子宫内膜癌的药物研发:最新进展
Oncol Res. 2025 Jun 26;33(7):1511-1530. doi: 10.32604/or.2025.061120. eCollection 2025.
3
Cancer treatment and survivorship statistics, 2025.2025年癌症治疗与生存统计数据
CA Cancer J Clin. 2025 Jul-Aug;75(4):308-340. doi: 10.3322/caac.70011. Epub 2025 May 30.
4
Generation and Maintenance of Patient-Derived Endometrial Cancer Organoids.患者来源的子宫内膜癌类器官的生成与维持。
Bio Protoc. 2024 Oct 20;14(20):e5093. doi: 10.21769/BioProtoc.5093.
5
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.癌症患者接受生物标志物导向治疗的分子检测的健康差异。
Cancer Res Commun. 2024 Oct 1;4(10):2598-2609. doi: 10.1158/2767-9764.CRC-24-0321.
6
Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.子宫平滑肌肉瘤的综合综述:发病机制、诊断、预后和靶向治疗。
Cells. 2024 Jun 26;13(13):1106. doi: 10.3390/cells13131106.
7
Trends in endometrial cancer incidence in the United States by race/ethnicity and age of onset from 2000 to 2019.2000年至2019年美国按种族/族裔和发病年龄划分的子宫内膜癌发病率趋势。
Am J Epidemiol. 2025 Jan 8;194(1):103-113. doi: 10.1093/aje/kwae178.
8
Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects.美国子宫癌发病率趋势:年龄、时期和队列效应的贡献。
Gynecol Oncol. 2024 Aug;187:151-162. doi: 10.1016/j.ygyno.2024.04.026. Epub 2024 May 22.
9
Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system.减少差异?:大型城市卫生系统中按种族、族裔和医院地点划分的治疗模式、生存率和复发率
Gynecol Oncol Rep. 2024 Mar 19;53:101372. doi: 10.1016/j.gore.2024.101372. eCollection 2024 Jun.
10
Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer.种族、POLE 和 POLD1 改变的流行率以及子宫内膜癌患者的生存。
JAMA Netw Open. 2024 Jan 2;7(1):e2351906. doi: 10.1001/jamanetworkopen.2023.51906.